Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
N. M. Kuderer
Observed names:
Kuderer,
N. Kuderer,
N.M. Kuderer,
NM Kuderer,
Nicole M. Kuderer
Institution:
Duke University
Observed institutions:
Duke University,
University of Washington,
University of Washington Medical Center,
University of Rochester Medicine,
Duke Medical Center,
Duke Cancer Institute
show all 6
OpenAlex ID:
A5062529227
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials
2013
·
G.H. Lyman
, D.C. Dale
, et al.
·
Annals of Oncology
·
221
PDF
Age and the Risk of Breast Cancer Recurrence.
1996
·
Lyman
, Lyman
, et al.
·
PubMed
·
45
Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy
2008
·
N. M. Kuderer
, C. W. Francis
, et al.
·
Journal of Clinical Oncology
·
31
LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
2020
·
T.M. Wise-Draper
, A. Desai
, et al.
·
Annals of Oncology
·
30
PDF
Personalized Medicine and Cancer Supportive Care: Appropriate Use of Colony-Stimulating Factor Support of Chemotherapy
2011
·
N. M. Kuderer
, G. H. Lyman
·
JNCI Journal of the National Cancer Institute
·
30
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
2020
·
P. Grivas
, J. Warner
, et al.
·
Annals of Oncology
·
14
PDF
Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study
2008
·
M. S. Poniewierski
, J. Crawford
, et al.
·
Journal of Clinical Oncology
·
6
Complications and costs associated with febrile neutropenia in hospitalized adult cancer patients
2004
·
N. M. Kuderer
, J. Crawford
, et al.
·
Journal of Clinical Oncology
·
6
Quality appraisal of clinical validation studies for multigene prediction assays of chemotherapy response in early-stage breast cancer.
2011
·
N. M. Kuderer
, E. Culakova
, et al.
·
Journal of Clinical Oncology
·
4
Impact of pegfilgrastim on early all-cause mortality in patients receiving cancer chemotherapy
2008
·
G. H. Lyman
, N. M. Kuderer
, et al.
·
Journal of Clinical Oncology
·
4
Risk and mortality associated with febrile neutropenia in lung cancer patients
2004
·
D. B. Daniel
, J. Crawford
, et al.
·
Journal of Clinical Oncology
·
3
A Primer for Evaluating Clinical Trials: An understanding of the limitations of design and conduct of clinical trials helps clinicians to assess the results
1997
·
Gary H. Lyman
, Nicole M. Kuderer
·
Cancer Control
·
3
P3-14-04: Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer.
2011
·
E Culakova
, MS Poniewierski
, et al.
·
Cancer Research
·
2
P5-13-17: Multigene Signature Assays in Patients with Early-Stage Breast Cancer (ESBC) Receiving Neoadjuvant Chemotherapy: An NCI-Funded Systematic Review and Evidence Summary of Predictive Performance.
2011
·
GH Lyman
, E Culakova
, et al.
·
Cancer Research
·
2
Improving quality at university based hematology/oncology fellowship continuity clinic with the quality oncology practice initiative (QOPI)
2008
·
A. M. Coscio
, A. Anguiano
, et al.
·
Journal of Clinical Oncology
·
2
Abstract P2-10-03: A cross-platform comparison of genomic signatures and OncotypeDx score to discover potential prognostic/predictive genes and pathways
2012
·
NM Kuderer
, WT Barry
, et al.
·
Cancer Research
·
1
P5-20-03: Personalizing Supportive Care: A Clinical Prediction Model for Neutropenic Complications in Patients with Early-Stage Breast Cancer (ESBC) Receiving Intermediate Risk Chemotherapy.
2011
·
NM Kuderer
, E Culakova
, et al.
·
Cancer Research
·
1
Overall survival in randomized controlled trials of chemotherapy (CT) with or without GCSF support: A systematic review.
2010
·
G. H. Lyman
, D. C. Dale
, et al.
·
Journal of Clinical Oncology
·
1
Acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) and overall mortality with chemotherapy (CT) and granulocyte colony-stimulating factor (G-CSF): A meta-analysis of randomized controlled trials (RCTs)
2009
·
G. H. Lyman
, D. C. Dale
, et al.
·
Journal of Clinical Oncology
·
1
Hospitalization with febrile neutropenia in colorectal cancer patients
2004
·
E. Culakova
, A. Khorana
, et al.
·
Journal of Clinical Oncology
·
1
OC-12 D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial
2021
·
S. Vadhan-Raj
, N.M. Kuderer
, et al.
·
Thrombosis Research
Abstract P1-15-04: The relationship of relative dose intensity and supportive care to febrile neutropenia rates in patients with early stage breast cancer receiving chemotherapy: a prospective cohort study of chemotherapy-associated toxicity
2012
·
E Culakova
, MS Poniewierski
, et al.
·
Cancer Research
Abstract P3-06-07: Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary
2012
·
GH Lyman
, E Culakova
, et al.
·
Cancer Research
Venous Thromboembolism (VTE) in Breast and Prostate Cancer Patients Receiving Chemotherapy – a us Real World Analysis of Risk and Economic Burden
2012
·
N. Kuderer
, H. Wang
, et al.
·
Annals of Oncology
Response: Re: Personalized Medicine and Cancer Supportive Care: Appropriate Use of Colony-Stimulating Factor Support of Chemotherapy
2011
·
N. M. Kuderer
, G. H. Lyman
·
JNCI Journal of the National Cancer Institute
PDF
Show more works
View as search
Works count:
30
Citation count:
408
H-index:
6
I10-index:
6
Year
Topic
Type